A marathon runner has said a prostate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying.

New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially when it comes to detecting more cancers at earlier stages when treatment is ...

Prostate cancer risk factors include some that can’t be changed, such as having a family history of the disease and a genetic predisposition for developing the cancer ...

IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

Dave Santee said he decided to take the Galleri test, a blood test that analyzes a person’s blood for DNA of cancer cells, ...

A new at-home spit test is better at predicting men's prostate cancer risk than current hospital tests, a new study shows. The test assesses 130 genetic variants in people's DNA to provide a risk ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...